The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Sat., Feb. 29, 2:02 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #59. BioReference Laboratories, Inc. Clinical laboratory in northern California

Acquirer: BioReference Laboratories, Inc. (BRLI)
Acquiree: Clinical laboratory in northern California
Details: BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today that it completed the acquisition of a clinical laboratory in northern California. The Company believes that the California acquisition represents significant strategic value to its national presence, as well as a significant presence in the California market.

Bio-Reference Laboratories is a clinical testing laboratory providing testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. Co. provides a list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. Co. mainly focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. Co. also operates a clinical knowledge management service through its PSIMedica business unit, and operates a web-based connectivity portal application through its CareEvolve subsidiary.

Open the BRLI Page at The Online Investor »

Company Name: 
Bio-Reference Laboratories, Inc.

Open the BRLI Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 59 of 100 Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.